Cancer and the microbiota
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
A host’s microbiota may increase, diminish, or have no effect at all on cancer susceptibility. Assigning causal roles in cancer to specific microbes and microbiotas, unraveling host-microbiota interactions with environmental factors in carcinogenesis, and exploiting such knowledge for cancer diagnosis and treatment are areas of intensive interest. This Review considers how microbes and the microbiota may amplify or mitigate carcinogenesis, responsiveness to cancer therapeutics, and cancer-associated complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss of microbial diversity (dysbiosis) is associated with chronic health conditions (26–28) and cancer (8–10), and is also associated with poor outcomes to certain forms of cancer therapy including allogeneic stem cell transplant (29).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“It has recently emerged that factors beyond tumor genomics influence cancer development and therapeutic responses (4–7), including host factors such as the gastrointestinal (gut) microbiome (8–10).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“their gene count that exceeds the human genome’s gene count by ~100-fold and enables diverse metabolic programming”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“the number of microbes that inhabit the human body (roughly equal to the number of human cells)”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“their effects on host immune system development and activity, including antitumor immunosurveillance (27–31).”
From The microbiome and human cancer (2021) · cites this paper as [31]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Self-citationMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Research works printed but not linked: 1
- 10.1111/j.1572-0241.2000.01860.x · doi:10.1111/j.1572-0241.2000.01860.x · Paper page
Cited by
Items 201–300 of 1,001
Gut microbiome: a new player in gastrointestinal disease
Gorkiewicz, G., & Moschen, A. R. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2277-x · Cited by 106
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
Lopetuso, L. R., Severgnini, M., Pecere, S., Ponziani, F. R., Boškoski, I., Larghi, A., Quaranta, G., Masucci, L., Ianiro, G., Camboni, T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231789 · Cited by 101
“Interestingly, the gastrointestinal (GI) microbiota has been demonstrated to exert a crucial role in health, as well as in several GI [5–8] and extra-intestinal diseases [9–12], and, also, in various types of cancers [13, 14].”
The Protective Effect of Polyphenols for Colorectal Cancer
Ding, S., Xu, S., Fang, J. Q., & Jiang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01407 · Cited by 93
“Intestinal Microbe Intestinal microbes play a key role in the integration of environmental factors with host physiology and metabolism, which may affect the occurrence and development of CRC through the changes of immune and metabolic signals mediated by metabolism, including the balance of intestinal cell proliferati…”
BackgroundA framework for microbiome science in public health
Wilkinson, J. E., Franzosa, E. A., Everett, C., Li, C., trainees, H. R. A., Bae, S., Berzansky, I., Bhosle, A., Bjørnevik, K., Brennan, C. A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01258-0 · Cited by 98
Self-citationMicroencapsulation for Pharmaceutical Applications: A Review
Yan, C., & Kim, S.-R. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00776 · Cited by 109
Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal Cancer
Ramos, A., & Hemann, M. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.018 · Cited by 89
From trash to treasure: detecting unexpected contamination in unmapped NGS data
Sangiovanni, M., Granata, I., Thind, A. S., & Guarracino, M. R. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2684-x · Cited by 96
Rangamuwa, K., Leong, T., Weeden, C. E., Asselin-Labat, M.-L., Bozinovski, S., Christie, M., John, T., Antippa, P. N., Irving, L. B., & Steinfort, D. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1075 · Cited by 95
“These include intrinsic tumour properties such as cytokine release (44) and genetic composition (44) [including tumour mutational burden (TMB)]; and extrinsic factors such as the gut microbiome (45-49), the presence of infection (44) and the exposure to sunlight (50).”
Gut Microbiota and Breast Cancer: The Dual Role of Microbes
Álvarez‐Mercado, A. I., Cano, A. D. V., Fernández, M. F., & Fontana, L. (2023) · Cancers · doi:10.3390/cancers15020443 · Cited by 104
“The loss of integrity of mucosal barriers stimulates pro-inflammatory programs with activation of pathways (such as NF-κB and STAT3) that are known to be involved in carcinogenesis [32].”
BackgroundUnderlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
Comen, E. A., Bowman, R. L., & Kleppe, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00056 · Cited by 99
Chen, X., Li, H., Hu, X., Zhang, Y., & Zhang, S. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000330 · Cited by 91
“[47,48] Wang et al[43] used metabonomics to investigate the relationship between the gut microbiota and CVD.”
BackgroundInfluentialThe stem cell division theory of cancer
López‐Lázaro, M. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.01.010 · Cited by 111
Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms
Wang, X., Yang, Y., & Huycke, M. M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.504 · Cited by 88
Iglesias-Santamaría, A. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02282-w · Cited by 90
Liu, S., Zhou, X., Peng, X., Li, M., Ren, B., Cheng, G., & Cheng, L. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901138 · Cited by 92
Pignatelli, P., Romei, F. M., Bondi, D., Giuliani, M., Piattelli, A., & Curia, M. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158323 · Cited by 100
“In these settings, the microbiota may influence carcinogenesis by altering host cell proliferation and death, perturbing immune system function, and influencing metabolism within a host [38] (Figure 2).”
BackgroundInfluentialYang, Q., Ouyang, J., Sun, F., & Yang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590685 · Cited by 90
Health-Improving Effects of Polyphenols on the Human Intestinal Microbiota: A Review
Nemzer, B. V., Al-Taher, F., Kalita, D., Yashin, A. Y., & Yashin, Y. I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031335 · Cited by 102
Bazin, T., Hooks, K. B., Barnetche, T., Truchetet, M., Enaud, R., Richez, C., Dougados, M., Hubert, C., Barré, A., Nikolski, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23571-4 · Cited by 89
Management of Patients With Immune Checkpoint Inhibitor-Induced Enterocolitis: A Systematic Review
Collins, M., Soularue, É., Marthey, L., & Carbonnel, F. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.01.033 · Cited by 93
The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies
Huybrechts, I., Zouiouich, S., Loobuyck, A., Vandenbulcke, Z., Vogtmann, E., Pisanu, S., Iguacel, I., Scalbert, A., Indave, I., Smelov, V., et al. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0288 · Cited by 80
“pylori infection causes gastric cancer and there are nine other microorganisms that are designated by the International Agency for Research on Cancer to be carcinogenic to humans (16, 17).”
BackgroundInfluentialCao, Y. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0188-9 · Cited by 94
Lv, Z., Liu, R., Su, K., Gu, Y.-M., Fang, L., Fan, Y., Gao, J., Ruan, X., & Feng, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.921119 · Cited by 89
Microbiota as a mediator of cancer progression and therapy
Pope, J. L., Tomkovich, S., Yang, Y., & Jobin, C. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.021 · Cited by 79
Beyond Metabolomics: A Review of Multi-Omics-Based Approaches
Beale, D. J., Karpe, A. V., & Ahmed, W. (2016) · Springer eBooks · doi:10.1007/978-3-319-46326-1_10 · Cited by 91
Mima, K., Ogino, S., Nakagawa, S., Sawayama, H., Kinoshita, K., Krashima, R., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., et al. (2017) · Surgical Oncology · doi:10.1016/j.suronc.2017.07.011 · Cited by 83
Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis
Iida, N., Mizukoshi, E., Yamashita, T., Yutani, M., Seishima, J., Wang, Z., Arai, K., Okada, H., Yamashita, T., Sakai, Y., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00251-3 · Cited by 81
Özdemir, B. C., Gerard, C. L., & da Silva, C. E. (2022) · Endocrinology · doi:10.1210/endocr/bqac058 · Cited by 86
Computer-guided design of optimal microbial consortia for immune system modulation
Stein, R. R., Tanoue, T., Szabady, R. L., Bhattarai, S. K., Olle, B., Norman, J. M., Suda, W., Oshima, K., Hattori, M., Gerber, G. K., et al. (2018) · eLife · doi:10.7554/elife.30916 · Cited by 76
Liu, J., Hsieh, C., Gelincik, O., Devolder, B., Sei, S., Zhang, Z., Lipkin, S. M., & Chang, Y. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2018.12.029 · Cited by 77
Neohesperidin prevents colorectal tumorigenesis by altering the gut microbiota
Gong, Y., Dong, R., Gao, X., Li, J., Li, J., Zheng, J., Cui, S., Ying, M., Yang, B., Cao, J., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104460 · Cited by 84
The gut microbiome and efficacy of cancer immunotherapy
Roviello, G., Iannone, L. F., Bersanelli, M., Mini, E., & Catalano, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107973 · Cited by 84
Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yang, Y., An, Y., Dong, Y., Chu, Q., Wei, J., Wang, B., & Cao, H. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.104967 · Cited by 90
“20,21 Meanwhile, it has become a clearer recognition that gut microbiota can exert an impact on both tumour development and tumour immuno-response fanned by the quick development of RNA and DNA sequencing, metabolic function analysis, bacterial identi fi cation and culture techniques, and…”
BackgroundRouty, B., Letendre, C., Enot, D., Chénard-Poirier, M., Mehraj, V., Séguin, N. C., Guenda, K., Gagnon, K., Woerther, P.-L., Ghez, D., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1258506 · Cited by 75
TLR4 Promotes Breast Cancer Metastasis via Akt/GSK3β/β‐Catenin Pathway upon LPS Stimulation
Li, J., Yin, J., Shen, W., Gao, R., Liu, Y., Chen, Y., Li, X., Liu, C., Xiang, R., & Luo, N. (2017) · The Anatomical Record · doi:10.1002/ar.23590 · Cited by 86
Sun, X., Zhao, D.-Y., Zhou, Y.-C., Wang, Q., Qin, G., & Yao, S. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i45.7173 · Cited by 82
Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions
Borella, F., Carosso, A. R., Cosma, S. D., Preti, M., Collemi, G., Cassoni, P., Bertero, L., & Benedetto, C. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00839 · Cited by 82
Gastrointestinal Microbiota and Colon Cancer
Hold, G. L. (2016) · Digestive Diseases · doi:10.1159/000443358 · Cited by 76
From Beyond the Pale to the Pale Riders: The Emerging Association of Bacteria with Oral Cancer
Fitzsimonds, Z. R., Hernandez, C. J. R., Bagaitkar, J., & Lamont, R. J. (2020) · Journal of Dental Research · doi:10.1177/0022034520907341 · Cited by 80
“These include modulation of the balance of host cell proliferation and death; disruption of immune surveillance; and alteration of the metabolism of host-produced compounds, nutritional substrates, or pharmaceuticals (Garrett 2015).”
BackgroundLi, S., Xia, H., Wang, Z., Zhang, X., Song, T., Li, J., Xu, L., Zhang, N., Fan, S., Li, Q., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000427 · Cited by 79
“[9] In recent years, tumor microenvironment (TME) has been demonstrated to play important roles in tumorigenesis and prognosis, [10,11] and a series of molecular subtyping of HCC has been established based on TME.”
Dysbiotic gut microbiome: A key element of Crohn's disease
Øyri, S. F., Műzes, G., & Sípos, F. (2015) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2015.10.005 · Cited by 84
Shang, J., Liu, F., Zhang, B., Dong, K., Lu, M., Jiang, R., Xu, Y., Diao, L., Zhao, J., & Tang, H. (2021) · PeerJ · doi:10.7717/peerj.11128 · Cited by 73
Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy
Chen, Y., Liu, B., Wei, Y., & Kuang, D.-M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105966 · Cited by 73
The interplay between human papillomavirus and vaginal microbiota in cervical cancer development
Sharifian, K., Shoja, Z., & Jalilvand, S. (2023) · Virology Journal · doi:10.1186/s12985-023-02037-8 · Cited by 92
Stem cell division theory of cancer
López‐Lázaro, M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1062330 · Cited by 76
The virtuous cycle of human genetics and mouse models in drug discovery
Nadeau, J. H., & Auwerx, J. H. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0009-9 · Cited by 83
Gut microbiota: A new piece in understanding hepatocarcinogenesis
Zhou, A., Tang, L., Zeng, S., Lei, Y., Yang, S., & Tang, B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.002 · Cited by 80
The microbiome in rheumatology: Where are we and where should we go?
Manasson, J., Blank, R. B., & Scher, J. U. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216631 · Cited by 79
Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity
Mowat, C., Dhatt, J., Bhatti, I., Hamie, A., & Baker, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1190810 · Cited by 82
“There is an increasing appreciation for the role played by the human microbiome in driving health and disease (1, 2).”
Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy
Longhi, G., van Sinderen, D., Ventura, M., & Turroni, F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575072 · Cited by 71
“Cancer may therefore result from the impact of various genetic factors acting in concert with a range of environmental and life-style associated insults (Garrett, 2015).”
BackgroundThe Role of the Microbiome in the Etiopathogenesis of Colon Cancer
Tekle, G. E., Andreeva, N., & Garrett, W. S. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042022-025619 · Cited by 86
Self-citationReprogramming the tumor microenvironment to enhance adoptive cellular therapy
Beavis, P. A., Slaney, C. Y., Kershaw, M. H., Gyorki, D. E., Neeson, P. J., & Darcy, P. K. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.11.003 · Cited by 80
Li, Q., Liu, R., Wu, T., & Zhang, M. (2017) · Food Research International · doi:10.1016/j.foodres.2017.02.021 · Cited by 72
Haas, O. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03136 · Cited by 80
Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis
Liu, X., Cui, D.-N., Li, Y., Liu, Y., Liu, G., & Liu, L. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i30.4199 · Cited by 76
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Samanta, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621999201210220442 · Cited by 81
Han, Z., Chen, Q., Zheng, D., Chen, K., Huang, Q., Zhuang, Z., & Zhang, X. (2023) · Advanced Materials · doi:10.1002/adma.202302551 · Cited by 73
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Zhang, H., Fu, L., Leiliang, X., Qu, C., Wu, W., Wen, R., Huang, N., He, Q., Cheng, Q., Liu, G., et al. (2024) · 癌症:英文版 · doi:10.1002/cac2.12597 · Cited by 78
“Some strains can express cytotoxin-associated gene A (CagA) protein, which is injected directly into the cytoplasm of host cells and induces tumor progression by regulating β -catenin to induce cancer [13, 156].”
BackgroundRole of the microbiome in non-gastrointestinal cancers
Pevsner-Fischer, M., Tuganbaev, T., Meijer, M., Zhang, S.-H., Zeng, Z.-R., Chen, M.-H., & Elinav, E. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i2.200 · Cited by 70
Publisher Correction: The gut–liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0031-8 · Cited by 70
Ganci, M., Suleyman, E., Butt, H., & Ball, M. (2019) · Brain and Behavior · doi:10.1002/brb3.1408 · Cited by 83
“…2016), depression (e.g., Jiang et al., 2015), obesity (Ley, Turnbaugh, Klein, & Gordon, 2006), diabetes (Larsen et al., 2010), coronary ar‐ tery disease (Cui, Zhao, Hu, Zhang, & Hua, 2017; Emoto et al., 2017), and cancer (particularly colorectal cancer; Gagniere et al., 2016; Garrett, 2015).”
Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues
He, Y., Zhang, Q., Yu, X., Zhang, S., & Guo, W. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03938-6 · Cited by 77
“Intratumoral microbes play a more direct role on a more local scale than gut microbes to influence tumour progression [8].”
BackgroundZhao, Z., Fei, K., Bai, H., Wang, Z., Duan, J., & Wang, J. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13711 · Cited by 84
Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy
Wu, J., Wang, S., Zheng, B. J., Qiu, X., Wang, H., & Chen, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669150 · Cited by 83
Organoids to study immune functions, immunological diseases and immunotherapy
Ye, W., Luo, C., Li, C., Huang, J., & Liu, F. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.027 · Cited by 67
The gut–liver axis: host microbiota interactions shape hepatocarcinogenesis
Silveira, M. A. D., Bilodeau, S., Greten, T. F., Wang, X. W., & Trinchieri, G. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.02.009 · Cited by 73
Kunath, B. J., Hickl, O., Queirós, P., Martin‐Gallausiaux, C., Lebrun, L., Halder, R., Laczny, C. C., Schmidt, T., Hayward, M. R., Becher, D., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01435-4 · Cited by 72
“The gut microbiome has been extensively studied primarily in the context of chronic diseases including cardiovascular diseases [15], inflammatory bowel disease [16], obesity [17], cancers [18], neurodegenerative diseases [19] or autoimmune conditions such as rheumatoid arthritis [20] or type 1 [21], and type 2 diabete…”
BackgroundGenomic Diversity of Enterotoxigenic Strains of Bacteroides fragilis
Pierce, J. V., & Bernstein, H. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158171 · Cited by 72
Song, B. C., & Bai, J. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-020-05739-9 · Cited by 65
Zhu, R., Lang, T., Yan, W., Zhu, X. G., Huang, X. Y., Yin, Q., & Li, Y. (2021) · Advanced Science · doi:10.1002/advs.202003542 · Cited by 67
Microbiota Biomarkers for Lung Cancer
Leng, Q., Holden, V. K., Deepak, J., Todd, N. W., & Jiang, F. (2021) · Diagnostics · doi:10.3390/diagnostics11030407 · Cited by 76
“Microbial agents could cause approximately 20% of the overall cancer burden [2].”
BackgroundInfluentialMingdong, W., Gao, X., Yongjun, Q., Mingshuai, W., & Hao, P. (2023) · BMC Cancer · doi:10.1186/s12885-023-11383-3 · Cited by 72
“In recent decades, with the application of immunotherapy in tumors, focusing on the organism immunity of tumors and the various factors that regulate the immune status is increasing, and gut microbiota is one of them [5].”
BackgroundDid the Brain and Oral Microbiota Talk to Each Other? A Review of the Literature
Maitre, Y., Micheneau, P., Delpierre, A., Mahalli, R., Guérin, M., Amador, G., & Denis, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123876 · Cited by 75
Diabetes and the Gut Microbiome
Lau, W. L., Tran, T., Rhee, C. M., Kalantar-Zadeh, K., & Vaziri, N. D. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.03.005 · Cited by 65
Molecular Mechanisms of Alcohol-Induced Colorectal Carcinogenesis
Johnson, C. H., Golla, J. P., Dioletis, E., Singh, S. P., Ishii, M., Charkoftaki, G., Thompson, D. C., & Vasiliou, V. (2021) · Cancers · doi:10.3390/cancers13174404 · Cited by 74
Greathouse, K. L., Wyatt, M., Johnson, A. J., Toy, E. P., Khan, J., Dunn, K., Clegg, D. J., & Reddy, S. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100800 · Cited by 73
The Role of The Tumor Microbiome in Tumor Development and Its Treatment
Chen, Y., Wu, F., Wu, P., Xing, H., & Ma, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935846 · Cited by 75
“HPV expresses oncogenic proteins E6 and E7, and gene expression levels of oncogenes and pathways are higher inHPV cervical cancer tissues compared to cervical cancer tissues without HPV integration (33, 36).”
BackgroundComparison of Metagenomics and Metatranscriptomics Tools: A Guide to Making the Right Choice
Terron-Camero, L. C., Gordillo-González, F., Salas‐Espejo, E., & Andrés‐León, E. (2022) · Genes · doi:10.3390/genes13122280 · Cited by 83
“Numerous studies and recent reviews have discussed different aspects of the microbiome and its possible role in human health, including in neonates and early life [22–24], but also regarding specific diseases such as cardiometabolic disorders [25], inflammatory bowel diseases [26,27], autoimmune diseases [28,29], neur…”
Hou, M., Ou‐Yang, F., Li, C.-L., Chen, F., Chuang, C., Kan, J., Wu, C.-C., Shih, S., Shiau, J., Kao, L.-C., et al. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00686-9 · Cited by 73
Protein restriction and cancer
Yin, J., Ren, W., Huang, X., Li, T., & Yin, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.03.004 · Cited by 69
Diversity of macaque microbiota compared to the human counterparts
Chen, Z., Yeoh, Y. K., Hui, M., Wong, P. Y., Chan, M. C. W., Ip, M., Yu, J., Burk, R. D., Chan, F. K. L., & Chan, P. K. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-33950-6 · Cited by 75
Wang, K., Huang, Y., Zhang, Z., Liao, J., Ding, Y., Fang, X., Liu, L., Luo, J., & Kong, J. (2019) · Medical Science Monitor · doi:10.12659/msm.915332 · Cited by 64
McQuade, J. L., Ologun, G. O., Arora, R., & Wargo, J. A. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00913-y · Cited by 63
Leveraging premalignant biology for immune-based cancer prevention
Spira, A. E., Disis, M. L., Schiller, J. T., Vilar, E., Rebbeck, T. R., Bejar, R. L., Ideker, T., Arts, J., Yurgelun, M. B. B., Mesirov, J. P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608077113 · Cited by 68
Ma, H., Yu, Y., Wang, M., Li, Z., Xu, H., Cheng, T., Zhang, J., Ye, X., & Li, X. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1500-9 · Cited by 67
Rébé, C., & Ghiringhelli, F. (2015) · Future Oncology · doi:10.2217/fon.15.198 · Cited by 72
Mørk, S. K., Kadivar, M., Bol, K. F., Draghi, A., Westergaard, M. C. W., Skadborg, S. K., Overgaard, N. H., Sørensen, A. B., Rasmussen, I. S., Andreasen, L. V., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2021.2023255 · Cited by 74
Tongue Coating Bacteria as a Potential Stable Biomarker for Gastric Cancer Independent of Lifestyle
Xu, S., Xiang, C., Wu, J., Teng, Y., Wu, Z., Wang, R., Lu, B., Zhan, Z., Wu, H., & Zhang, J. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06637-0 · Cited by 64
Microbes in gynecologic cancers: Causes or consequences and therapeutic potential
Wahid, M., Dar, S. A., Jawed, A., Mandal, R. K., Akhter, N., Khan, S. A., Khan, F., Jogaiah, S., Kumar, A., & Rattan, R. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.07.013 · Cited by 81
Wei, H., Wang, H., Tang, L., Mu, C., Ye, C., Chen, L., & Wang, C. (2019) · BMC Genomics · doi:10.1186/s12864-019-6219-7 · Cited by 65
Global research trends on the links between the gut microbiome and cancer: a visualization analysis
Zyoud, S. H., Al‐Jabi, S. W., Amer, R. A., Shakhshir, M. H., Shahwan, M. J., Jairoun, A. A., Akkawi, M., & Taha, A. A. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03293-y · Cited by 70
The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment
Gao, F., Yu, B., Rao, B., Sun, Y. H., Yu, J., Wang, D., Cui, G., & Ren, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1051987 · Cited by 71
“and alter the local immune environment of tumors, thereby promoting tumor cell growth (4, 5, 21, 22, 43).”
BackgroundInfluentialAn Organ‐on‐Chip Platform for Simulating Drug Metabolism Along the Gut–Liver Axis
Lucchetti, M., Aina, K. O., Grandmougin, L., Jäger, C., Escriva, P. P., Letellier, E., Mosig, A. S., & Wilmes, P. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303943 · Cited by 79
Roles of microbiota in response to cancer immunotherapy
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.026 · Cited by 65
Milestones in the pathogenesis and management of primary liver cancer
Nault, J., Cheng, A., Sangro, B., & Llovet, J. M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.006 · Cited by 64
Structure of the Mucosal and Stool Microbiome in Lynch Syndrome
Yan, Y., Drew, D. A., Markowitz, A. J., Lloyd‐Price, J., Abu-Ali, G., Nguyen, L. H., Tran, C., Chung, D. C., Gilpin, K. K., Meixell, D. A., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.005 · Cited by 67
“In addition to such genetic predisposition, environmental factors contribute substantially to CRC risk (Drewes et al., 2016; Garrett, 2015; Segre, 2015), particularly the intestinal microbiota (Belcheva et al.”
InfluentialSelf-citationMicrobial biomarkers of common tongue coatings in patients with gastric cancer
Xu, J., Xiang, C., Zhang, C., Xu, B., Wu, J., Wang, R., Yang, Y., Shi, L., Zhang, J., & Zhan, Z. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.11.051 · Cited by 59
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 72
Shi, Z., Li, M., Zhang, C., Li, H., Zhang, Y., Zhang, L., Li, X., Li, L., Wang, X., Fu, X., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-333530 · Cited by 72
“28 29 Among these, contact-dependent effects occurring directly at the mucosal surface or within the tumour microenvironment are relatively well understood.”
Pujada, A., Walter, L., Patel, A. R., Bui, T. A., Zhang, Z., Zhang, Y., Denning, T. L., & Garg, P. (2017) · Oncotarget · doi:10.18632/oncotarget.21841 · Cited by 62
Metadata
- Authors
- Garrett, W. S.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- ORCID
- Garrett, Wendy S.
- Venue
- Science
- Published
- 2015-04-03
- Volume
- 348
- Issue
- 6230
- Pages
- 80-86
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5535753
- OpenAlex
- W2073924079
- Cited by
- 1,404
- References
- 119
- Citations by year
- 2026: 145 · 2025: 169 · 2024: 169 · 2023: 151 · 2022: 162 · 2021: 141 · 2020: 127 · 2019: 106 · 2018: 77 · 2017: 68 · 2016: 58 · 2015: 29
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01CA154426)
- Burroughs Wellcome Career in Medical Sciences Award
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- gut microbiota, cancer susceptibility, carcinogenesis, host-microbe interactions, cancer therapy response, cancer diagnosis
- MeSH terms
- Humans, Immunotherapy, Neoplasms, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.